Anuh Pharma gains after receiving WHO prequalification for Sulfadoxine
Anuh Pharma surged 5.8% to Rs 330 at 09:35 IST on BSE after the company received World Health Organization prequalification for the product Sulfadoxine.
The company made the announcement after market hours yesterday, 16 December 2015.
Meanwhile, the BSE Sensex was up 70.10 points, or 0.27%, to 25,564.47
On BSE, so far 25,000 shares were traded in the counter, compared with an average volume of 22,936 shares in the past one quarter.
The stock hit a high of Rs 339 and a low of Rs 320 so far during the day. The stock hit a 52-week low of Rs 103.70 on 22 December 2014. The stock hit a record high of Rs 414.75 on 12 August 2015.
The small-cap pharma firm has an equity capital of Rs 12.53 crore. Face value per share is Rs 5.
Anuh Pharma's net profit surged 56.4% to Rs 7.43 crore on 28.2% rise in total income to Rs 90.44 crore in Q2 September 2015 over Q2 September 2014.
Anuh Pharma manufactures active pharmaceutical ingredients (API's). The company is one of the largest producers of macrolides in the country.
Powered by Capital Market - Live News